Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control and Prevention

Choi Hyo-Geun; Wee Jee Hye; Kim So Young; Kim Joo-Hee; Kim Hwan I; Park Ji-Young; Park Sunghoon; Hwang Yong I; Jang Seung Hun; Jung Ki-Suck

首页> 外文期刊>Allergy >Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control and Prevention

【24h】

Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control and Prevention

机译：Covid-19患者哮喘与临床死亡率/发病率的关联，韩国病害控制和预防临床流行病学数据

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Allergy》 |2021年第3期|共4页
作者
Choi Hyo-Geun; Wee Jee Hye; Kim So Young; Kim Joo-Hee; Kim Hwan I; Park Ji-Young; Park Sunghoon; Hwang Yong I; Jang Seung Hun; Jung Ki-Suck;
展开▼
作者单位

Hallym Univ Coll Med Sacred Heart Hosp Dept Otolaryngol Head &

Neck Surg Anyang South Korea;

Hallym Univ Coll Med Sacred Heart Hosp Dept Otolaryngol Head &

Neck Surg Anyang South Korea;

Hallym Univ Coll Med Sacred Heart Hosp Dept Otolaryngol Head &

Neck Surg Anyang South Korea;

Hallym Univ Coll Med Sacred Heart Hosp Div Pulm Allergy &

Crit Care Med Dept Med Anyang South;

Hallym Univ Coll Med Sacred Heart Hosp Div Pulm Allergy &

Crit Care Med Dept Med Anyang South;

Hallym Univ Coll Med Sacred Heart Hosp Div Pulm Allergy &

Crit Care Med Dept Med Anyang South;

Hallym Univ Coll Med Sacred Heart Hosp Div Pulm Allergy &

Crit Care Med Dept Med Anyang South;

Hallym Univ Coll Med Sacred Heart Hosp Div Pulm Allergy &

Crit Care Med Dept Med Anyang South;

Hallym Univ Coll Med Sacred Heart Hosp Div Pulm Allergy &

Crit Care Med Dept Med Anyang South;

Hallym Univ Coll Med Sacred Heart Hosp Div Pulm Allergy &

Crit Care Med Dept Med Anyang South;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result A prospective, historically controlled, multi-center clinical study [J] . ZHANG Qi, HONG Tao, CHEN Ji-lin, 中华医学杂志（英文版） . 2007,第007期
2. Epidemiologic Features, Radiological Findings and Clinical Outcomes of 19 Patients with COVID-19 in a Single Center in Beijing, China [J] . Lan Song, Wei Song, Zhengyu Jin, 中国医学科学杂志（英文版） . 2021,第002期
3. Epidemiological characteristics and clinical manifestations of pediatric patients with COVID-19 in China:A multicenter retrospective study [J] . Yan Bai, Lina Wang, Mingfeng Han, 儿科学（英文） . 2021,第003期
4. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure [J] . FoxK., FordI., StegP.G., The American heart journal . 2013,第4期

机译：研究的基本原理，设计和基线特征评估了冠状动脉疾病患者中If抑制剂ivabradine的发病率-死亡率（SIGNIFY试验）：稳定冠心病患者使用ivabradine的随机，双盲，安慰剂对照试验没有临床心力衰竭的动脉疾病
5. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure [J] . FoxK., FordI., StegP.G., The American heart journal . 2013,第4期

机译：研究评估冠状动脉疾病患者抑制剂IVABRADINE的发病率，设计和基线特征，评估冠状动脉疾病患者的发病率 - 死亡率（意思是试验）：稳定冠状动脉患者Ivabradine的随机，双盲，安慰剂对照试验没有临床心力衰竭的动脉疾病
6. Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case-control and survival analysis using the United Kingdom Clinical Practice Research Datalink [J] . Nakafero Georgina, Sanders Robert D., Nguyen-Van-Tam Jonathan S., Pharmacoepidemiology and drug safety . 2015,第8期

机译：苯二氮卓类药物的使用与哮喘患者病情加重和死亡率之间的关联：使用英国临床实践研究数据链接进行匹配的病例对照和生存分析
7. GEPAR-NET: a tool to collect clinical data for an epidemiological study of the gastroesophageal reflux disease [C] . Giacomini, M., DeAntoni, . 2002

机译：GEPAR-NET：收集用于胃食管反流病流行病学研究的临床数据的工具
8. The exploration and development of a causal model for asthma morbidity by confirmatory factor analysis and path analysis utilizing common clinical variables. [D] . Miller, Thomas Paul. 2007

机译：通过验证性因素分析和利用常见临床变量的路径分析，探索和开发哮喘发病原因模型。
9. Evaluation of Mortality and Morbidity According to Initial Symptoms in COVID-19 Patients Using Clinical Epidemiologic Data from the Korea Centers for Disease Control Prevention [O] . So Young Kim, Dae Myoung Yoo, Chanyang Min, 2021

机译：根据Covid-19患者的初始症状评估死亡率和发病率使用来自韩国疾病控制和预防韩国中心的临床流行病学数据的初始症状
10. Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control and Prevention [O] . Hyo‐Geun Choi, Jee Hye Wee, So Young Kim, 2020

机译：Covid-19患者哮喘与临床死亡率/发病率之间的关联 - 来自韩国疾病控制和预防的临床流行病学数据
11. Morbidity and Mortality Weekly Report, March 28, 2003, Volume 52, Number RR-6. Key Clinical Activities for Quality Asthma Care: Recommendations of the National Asthma Education and Prevention Program [R] . Hewitt, S. M. 2003

机译：发病率和死亡率每周报告，2003年3月28日，第52卷，RR-6号。优质哮喘护理的主要临床活动：国家哮喘教育和预防计划的建议

Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control and Prevention

著录项

相似文献

相关主题

期刊订阅